T Cell Cytokine Secretion Analysis Service
CD BioGlyco provides a specialized T cell cytokine secretion analysis service, categorized under our mRNA bioanalysis service within the broader mRNA-based vaccine development. T cells play a pivotal role in the immune response to mRNA-encoded antigens, and their ability to secrete specific cytokines, such as interferon-gamma (IFN-γ), interleukin-2 (IL-2), and tumor necrosis factor-alpha (TNF-α), is a primary indicator of vaccine potency and therapeutic efficacy. By measuring the concentration, frequency, and polyfunctionality of cytokine-secreting cells, we help researchers decipher the complex interactions between mRNA delivery systems and the host immune system. Whether you are optimizing a lipid nanoparticle (LNP) formulation or validating a new neoantigen candidate, our bioanalytical expertise ensures your project moves forward with confidence.
These assays allow for the detection of cytokine secretion at the single-cell level with unparalleled sensitivity. While ELISpot is the gold standard for quantifying the frequency of cytokine-producing cells, FluoroSpot enables the simultaneous detection of multiple cytokines from a single cell, providing a direct measure of polyfunctionality.
ICS is essential for identifying the specific cellular source of cytokines. By utilizing fluorochrome-conjugated antibodies and protein transport inhibitors, we simultaneously assess surface markers (e.g., CD3, CD4, CD8) and intracellular cytokines, offering a multidimensional view of the T cell response.
Technologies such as electrochemiluminescence (ECL) allow for the high-throughput quantification of dozens of soluble cytokines in cell culture supernatants or serum. This provides a comprehensive "cytokine storm" or "inflammatory profile" from a single, small-volume sample.
As part of our mRNA bioanalysis service, we offer a comprehensive suite of analysis methods tailored to the unique requirements of mRNA-based products. Our scope covers the characterization of various "sub-substances" and functional profiles:
We quantify the balance of T-helper (Th) cell responses. mRNA vaccines often aim for a Th1-biased response to ensure safety and avoid vaccine-associated enhanced respiratory disease (VAERD).
We measure the ability of individual T cells to produce multiple cytokines simultaneously (e.g., IFN-γ, TNF-α). High polyfunctionality is frequently correlated with superior protective immunity.
Our team performs longitudinal studies to track how cytokine levels evolve post-vaccination or post-treatment, providing critical data for dosage and scheduling optimization.
We evaluate the ability of mRNA-induced T cells to recognize and respond to variant antigens or related pathogen strains.
We accept various sample types, including fresh whole blood or cryopreserved peripheral blood mononuclear cells (PBMCs). Our specialized protocols ensure maximum cell viability and recovery, which is critical for functional assays.
Cells are stimulated with specific mRNA-encoded proteins, overlapping peptide pools, or even through direct transfection of the mRNA of interest. We include positive controls and negative controls to validate assay performance.
For FluoroSpot, cells are incubated on membranes pre-coated with capture antibodies. For ICS, protein transport inhibitors are added to trap cytokines within the endoplasmic reticulum.
Samples undergo multi-step staining. This includes surface marker labeling, cell fixation/permeabilization, and the addition of biotinylated or fluorescently labeled detection antibodies.
Using advanced flow cytometers or high-resolution plate readers, we capture raw signal data. Our equipment is calibrated daily to ensure sensitivity and minimize batch-to-batch variation.
Raw data is processed using specialized software. We provide detailed reports including spot-forming unit (SFU) counts, gating strategies, population percentages, and statistical comparisons across experimental groups.
DoI: 10.1038/s41467-020-15543-y
Journal: Nature Communications
IF: 15.7
Published: 2020
Results: This study employs multi-omics (bulk RNA-seq and proteomics of over 40,000 cells) to investigate cytokine responses in human naïve (Tn) and memory (Tm) CD4+ T cells. Key findings reveal Tm cannot differentiate into Th2 and acquire a Th17-like phenotype under iTreg polarization, unlike Tn which respond to all tested cytokine conditions. Analyses identify a transcriptional continuum from Tn to central/effector memory T cells, forming an "effectorness gradient" with increased chemokine/cytokine expression. This gradient, linked to T cell activation history and clonal expansion, shapes responses to activation and cytokines, e.g., IFNγ secretion correlates with effectorness. The study highlights T cell heterogeneity, showing effectorness and cytokine stimulation jointly modulate transcriptomes, advancing understanding of inflammation and immune cell plasticity.
Fig.1 The experimental design of RNA-seq analysis. (Cano-Gamez, et al., 2020)
mRNA Vaccine Development
Quantitative assessment of T cell immunogenicity for infectious disease vaccines. Our data support "Go/No-Go" decisions during preclinical research.
Cancer Immunotherapy
Monitoring the activation and cytokine profiles of T cells targeting tumor-associated antigens (TAAs) or neoantigens delivered via mRNA platforms.
Adoptive Cell Therapy (ACT)
Evaluation of CAR-T or TCR-T cell functional potency. We measure cytokine secretion as a correlate of the cells' cytotoxic potential and persistence.
Autoimmune Disease Research
Investigating the modulation of regulatory T cell (Treg) cytokine profiles (e.g., IL-10, TGF-β) in response to tolerogenic mRNA therapies.
High Sensitivity and Low Detection Limits
Our optimized ICS protocols detect rare antigen-specific T cell populations, with a limit of detection (LOD) as low as 1 in 100,000 cells.
Customizable Multiplex Panels
CD BioGlyco offers flexible panel designs, allowing you to choose from over 50 different human, mouse, or non-human primate (NHP) cytokines to fit your specific research goals.
Expert PhD-Level Consultation
Every project is overseen by experienced immunologists who assist in experimental design, antigen selection, and complex data interpretation, ensuring scientific rigor.
End-to-End mRNA Bioanalysis Integration
As a leader in the field, we seamlessly link cytokine analysis with other mRNA services, such as LNP characterization and mRNA integrity testing.
Their T cell cytokine profiling was instrumental in demonstrating the Th1-bias of our candidate. The data was delivered ahead of schedule and met all our requirements.
— C.Y., Biopharma Corporation
The depth of information provided by their polyfunctional T cell indexing service allowed us to differentiate between three lead LNP formulations that appeared identical in initial screens.
— C.R., Biotech Research Institute
Reliable, professional, and scientifically rigorous. Their team's expertise in handling samples for our preclinical mRNA program was impressive. Highly recommended.
— B.W., Medical Center
At CD BioGlyco, we understand that the success of your mRNA-based therapy hinges on a deep understanding of the cellular immune response. Our T cell cytokine secretion analysis service combines cutting-edge technology with scientific expertise to provide the insights you need to advance your pipeline. Please feel free to contact us for detailed information on our services or to request a formal quotation.
Reference
